Abstract
The hepatoprotective effects of misoprostol, a PGE1 analog, against ischemiareperfusion liver injury were studied using a rat partial liver ischemia model. Serum ornithine carbamoyltransferase (OCT) and alanine aminotransferase (ALT) levels were determined as biochemical indices of injury. Hepatic cell necrosis was assessed histologically using tetranitroblue tetrazolium (TNBT) and hematoxylin and eosin (H&E) staining. With placebo treatment, 90 min of partial hepatic ischemia followed by 24 hr of reperfusion resulted in increased levels of serum OCT (760±521IU/liter) and ALT (4327 ±1982 IU/liter), while extensive hepatic necrosis was evident by TNBT and H&E staining. Treatment with two doses of 25 μg misoprostol/kg body weight at 1 min before ischemia and 1 min before reperfusion significantly reduced the serum levels of OCT and ALT (207±189 IU/liter, P<0.01 and 2075±1217 IU/liter, P<0.01, respectively) and hepatic necrosis. When a single dose of misoprostol was administered 1 min before reperfusion, similar protective effects were observed. However, when the treatment of misoprostol was delayed to 1 min after reperfusion, significantly less hepatoprotection was seen. Misoprostol exerted no hepatoprotection at all when it was administered at 5 min or later after reperfusion. These results demonstrate that misoprostol partially protects the liver against ischemia-reperfusion injury in the rat. The observation that the protective effect of misoprostol occurs only within the first minute of reperfusion suggests that its mechanism of action involves an early event in reperfusion injury, such as modifying the effects of reactive oxygen metabolites.
Similar content being viewed by others
References
Delva E, Barberousse JP, Nordlinger B, Ollivier JM, Vacher B, Guilmet C, Huguet C: Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 95:309–318, 1984
Cello JP, Sleisenger MH: The liver in systemic conditions.In Hepatology: A Text Book of Liver Disease. D Zakim, TD Boyer (eds) Philadelphia, WB Saunders Company, 1982, pp 1221–1249
Cahalan MK, Mangano DT: Liver function and dysfunction with anesthesia and surgery.In Hepatology: A Text Book of Liver Disease. D Zakim, TD Boyer (eds). Philadelphia, WB Saunders Company, 1982, pp 1250–1261
Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205–211, 1979
McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159–163, 1985
Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest 47:412–426, 1982
Robert A: Cytoprotection by prostaglandins. Gastroenterology 77:761–767, 1979
Ogletree ML, Lefer AM, Smith JB, Nocolaou KC: Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol 56:95–103, 1979
Kaufman RP, Kobzik L, Shepro D, Anner H, Valeri CR, Hechtman HB: Vasodilator prostaglandins (PG) prevent renal damage after ischemia. Ann Surg 205:195–198, 1987
Stachura J, Tarnawski A, Ivey KJ, Mach T, Bogdal J, Szczudrawa J, Klimczyk B: Prostaglandin protection of carbon tetrachloride induced liver cell necrosis in the rat. Gastroenterology 81:211–217, 1981
Stachura J, Tarnawski A, Szczudrawa J, Bogdal J, Mach T, Klimczyk B, Kirchmayer S: Cytoprotective effect of 16, 16-dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat. Folia Histochem Cytochem 18:311–318, 1980
Makowka L, Falk RE, Cohen MM, Falk JA, Langer B, Blendis LM, Philips MJ: Protective effect of 16,16-dimethyl prostaglandin E2 on acute ethanol-induced inhibition of hepatic regeneration. Surg Forum 33:183–186, 1982
Frederiks WM, James J, Bosch KS, Schroder MJR, Schuyt HC: A model for provoking ischemic necrosis in rat liver parenchyma and its quantitative analysis Exp Pathol 22:245–252, 1982
Ohshita M, Takeda H, Kamiyama Y, Ozawa K, Honjo I: A direct method for the estimation of ornithine carbamoyl-transferase activity in serum. Clin Chim Acta 67:145–152, 1976
Reitman S, Frankel S: A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63, 1957
Frederiks WM, Fronik GM, Hesseling JMG: A method for quantitative analysis of the extent of necrosis in ischemic rat liver. Exp Mol Pathol 41:119–125, 1984
Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187:185–194, 1973
Guilford JP: Fundamental Statistics in Psychology and Education, 5th ed. Tokyo, McGraw-Hill, 1973, p 263
Siegel S, Castellan NJ: Nonparametric Statistics for the Behavioral Sciences, 2nd ed. New York, McGraw-Hill, 1988 pp 284–291
Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MFX, Langer B, Levy GA: Treatment of primary liver graft nonfunction with prostaglandin E1. Fransplantation 48:447–453, 1989
Miyazaki M, Makowka L, Falk RE, Falk JA, McDonell M, Venturi D: Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2. J Surg Res 34:415–426, 1983
Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA: 16, 16-Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 80:881–889, 1987
Popper H: Morphologic features of hepatocellular necrosis in human disease.In Pathogenesis and Mechanism of Liver Cell Necrosis. D Keppler (ed). St. Leonard House, Lancaster, MTP Press, 1975, pp 15–24
Araki H, Lefer AM: Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol 238:H176-H181, 1980
Sikujara O, Monden M, Toyoshima K, Okamura J, Kosaki G: Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury. Transplantation 36:238–243, 1983
Adkison D, Hollwarth ME, Benoit JN, Parks DA, McCord JM, Granger DN: Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol Scand 548(suppl):101–107, 1986
Colletti LM, Burtch GD, Campbell DA: Prostaglandin E2 protects the isolated perfused rabbit liver from an oxygen free radical-induced injury. Transplant Proc 22:2381–2383, 1990
Guarner F, Fremont-Smith M, Prieto J: Cytoprotective effect of prostaglandins on isolated rat liver cells. Liver 5:35–39, 1985
Halliwell B: Superoxide, iron, vascular endothelium and reperfusion injury. Free Rad Res Commun 5:315–318, 1989
Misoprostol (Cytotec). Preclinical and clinical review. Glenview, Illinois, Physicans and Scientists Publishing, 1990
Author information
Authors and Affiliations
Additional information
This study is supported by the Australian National Health and Medical Research Council Grant 91/0662.
Rights and permissions
About this article
Cite this article
Lim, S.P., Andrews, F.J., Christophi, C. et al. Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat. Digest Dis Sci 37, 1275–1281 (1992). https://doi.org/10.1007/BF01296572
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296572